China continues to step up its probe into alleged bribery by British drugmaker GlaxoSmithKline to illegally boost sales and inflate the price of its medicines.
Top fraud investigators have said that senior Chinese executives from the firm passed bribes to government officials, doctors, hospitals and industry associations using travel agencies as conduits for the cash.
...
http://www.euronews.net/
